Paid Clinical Trials in Georgia

Georgia has 2,067 paid clinical trials enrolling now across cities including Atlanta, Decatur and Augusta. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Georgia include Emory University Hospital and Winship Cancer Institute, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 31, 2026.

Filter results

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

1,853 clinical trials

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

for Acute Promyelocytic Leukemia (APL)

Sites in Augusta +9 more locations

Sponsor: Quetzal Therapeutics

Sex: All·Age: 18 - 71

Code: NCT07504458·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia

for Schizophrenia

Drug: GXV813

Sites in Decatur +6 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 65

Code: NCT07467993·Phase 2·Recruiting·Listed Mar 2026

Apply to this trial

A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant

for Renal Transplant Failure and Rejection

Sites in Atlanta +1 more location

Sponsor: Nefro Avillion Clinical Development, LLC

Sex: All·Age: 18 - 70

Code: NCT07508787·Phase 2·Recruiting·Listed Apr 2026

Apply to this trial

A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Angiokeratomas (LOTU)

for Angiokeratomas

Sites in Dawsonville +3 more locations

Sponsor: Palvella Therapeutics, Inc.

Sex: All·Age: 6+

Code: NCT07552077·Phase 2·Recruiting·Listed Apr 2026

Apply to this trial

Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy

for Relapsed or Refractory Large B-cell Lymphoma

Sites in Newnan +5 more locations

Sponsor: Kite, A Gilead Company

Sex: All·Age: 18+

Code: NCT07479797·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

for Carcinoma

Drug: PF-08634404

Sites in Athens +6 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07489066·Phase 2·Recruiting·Listed Mar 2026

Apply to this trial

A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

for Colitis Ulcerative

Sites in Macon +8 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18 - 75

Code: NCT07463183·Phase 2·Recruiting·Listed Mar 2026

Apply to this trial

A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)

for T Cell Malignancies

Sites in Atlanta +5 more locations

Sponsor: Electra Therapeutics Inc.

Sex: All·Age: 18+

Code: NCT07465835·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers

for Advanced Malignancies

Sites in Atlanta +16 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07426757·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

Investigation of the Delve Detect Cerebrospinal Fluid (CSF) Metagenomic Next-generation Sequencing (mNGS) Test When Used for the Initial Diagnostic Workup of Patients With Suspected Central Nervous System (CNS) Infection

for Central Nervous System Infection

Sites in Atlanta +3 more locations

Sponsor: Delve Bio, Inc.

Sex: All·Age: All ages

Code: NCT07435649·Recruiting·Listed Feb 2026

Apply to this trial

A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)

for High Risk Smoldering Multiple Myeloma (HR-SMM)

Drug: Linvoseltamab

Sites in Atlanta +1 more location

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07393282·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI

for Coronary Artery Disease (CAD)

1 location in Marietta

Sponsor: HeartFlow, Inc.

Sex: All·Age: 18+

Code: NCT07479433·Recruiting·Listed Mar 2026

Apply to this trial

A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

for Multiple Myeloma

Sites in Newnan +4 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT07409246·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

for Colorectal Cancer

Sites in Atlanta +9 more locations

Sponsor: Cartography Biosciences

Sex: All·Age: 18+

Code: NCT07321106·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

An Efficacy and Safety Study of DFL24498 in the Treatment of AKC

for Atopic Keratoconjunctivitis

Sites in Morrow +7 more locations

Sponsor: Dompé Farmaceutici S.p.A

Sex: All·Age: 18 - 65

Code: NCT07395232·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

Long-Term Outcomes of Teplizumab in Routine Clinical Care

for Type 1 Diabetes

Sites in Atlanta +3 more locations

Sponsor: Sanofi

Sex: All·Age: All ages

Code: NCT07360080·Recruiting·Listed Jan 2026

Apply to this trial

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

for Advanced HR+/HER2- Breast Cancer

Drug: GVV858

Sites in Atlanta +2 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07288359·Phase 1, Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors

for Large Cell Neuroendocrine Carcinoma

Sites in Atlanta +4 more locations

Sponsor: Molecular Partners AG

Sex: All·Age: 18+

Code: NCT07278479·Phase 1, Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool

for PTSD - Post Traumatic Stress Disorder

Sites in Savannah +4 more locations

Sponsor: Senseye, Inc.

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07280065·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.

for Clostridioides Difficile Infection Recurrence

Sites in Atlanta +3 more locations

Sponsor: Bactolife A/S

Sex: All·Age: 18+

Code: NCT07250724·Recruiting·Listed Nov 2025

Apply to this trial

A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis

for Atopic Dermatitis

Drug: Afimkibart

Sites in Alpharetta +2 more locations

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT07223697·Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)

for Locally Advanced Basal Cell Carcinoma

Sites in Atlanta +2 more locations

Sponsor: Philogen S.p.A.

Sex: All·Age: 18 - 100

Code: NCT07227350·Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

for Depressive Disorder, Major

Sites in Atlanta +5 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 12 - 17

Code: NCT07227454·Phase 3·Recruiting·Listed Nov 2025

Apply to this trial

A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.

for Ankle Arthrodesis or Arthroplasty

Sites in Columbus +5 more locations

Sponsor: Kuros Biosurgery AG

Sex: All·Age: 18 - 75

Code: NCT07225751·Recruiting·Listed Nov 2025

Apply to this trial

A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma

for Squamous Cell Carcinoma of Head and Neck

Sites in Atlanta +8 more locations

Sponsor: Johnson & Johnson Enterprise Innovation Inc.

Sex: All·Age: 18 - 74

Code: NCT07219212·Phase 1·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

for Relapsed and/or Refractory Multiple Myeloma (RRMM)

Drug: Linvoseltamab

Sites in Atlanta +3 more locations

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07222761·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure

for Unresectable or Metastatic Hepatocellular Carcinoma

Drug: Nivolumab

Sites in Atlanta +2 more locations

Sponsor: CatalYm GmbH

Sex: All·Age: 18 - 100

Code: NCT07219459·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)

for Progressive Metastatic Castrate Resistant Prostate Cancer

Drug: Tulmimetostat

Sites in Atlanta +6 more locations

Sponsor: Novartis Pharmaceuticals

Sex: Male·Age: 18+

Code: NCT07206056·Phase 1, Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

STAR Trial (Siegel Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis)

for Symptomatic Severe Native Aortic Stenosis

1 location in Atlanta

Sponsor: MiRus

Sex: All·Age: 18+

Code: NCT07278310·Recruiting·Listed Dec 2025

Apply to this trial

Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy

for Invasive Mould Infection

Sites in Augusta +6 more locations

Sponsor: Elion Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07215273·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania

for Bipolar I Disorder

Drug: NBI-1117568

Sites in Atlanta +5 more locations

Sponsor: Neurocrine Biosciences

Sex: All·Age: 18 - 65

Code: NCT07288320·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

for Non-small Cell Lung Cancer (NSCLC)

Sites in Atlanta +8 more locations

Sponsor: Astellas Pharma Global Development, Inc.

Sex: All·Age: 18+

Code: NCT07140016·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

A Study to Learn About How Well BAY 3401016 Works in Adults With Alport Syndrome

for Alport Syndrome

Sites in Atlanta +5 more locations

Sponsor: Bayer

Sex: All·Age: 18 - 45

Code: NCT07211685·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

for Sickle Cell Disease

Sites in Atlanta, Augusta +6 more locations

Sponsor: Disc Medicine, Inc

Sex: All·Age: 18+

Code: NCT07187973·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)

for Pompe Disease

Sites in Atlanta +8 more locations

Sponsor: Shionogi

Sex: All·Age: 18+

Code: NCT07123155·Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis

for Moderately to Severely Active Ulcerative Colitis

Drug: Afimkibart

Sites in Atlanta +2 more locations

Sponsor: Hoffmann-La Roche

Sex: All·Age: 2 - 17

Code: NCT07158242·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia

for Congenital Adrenal Hyperplasia

Sites in Atlanta +9 more locations

Sponsor: Crinetics Pharmaceuticals Inc.

Sex: All·Age: 18 - 74

Code: NCT07144163·Phase 3·Recruiting·Listed Aug 2025

Apply to this trial

Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B

for Hemophilia B

Sites in Atlanta +4 more locations

Sponsor: CSL Behring

Sex: Male·Age: 138 Months - 206 Months

Code: NCT07080905·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

for Schizophrenia

Drug: KarXT

Sites in Atlanta, Decatur +6 more locations

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18 - 55

Code: NCT07061288·Phase 1·Recruiting·Listed Jul 2025

Apply to this trial

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

for Non Small Cell Lung Cancer

Sites in Athens +8 more locations

Sponsor: Compass Therapeutics

Sex: All·Age: 18+

Code: NCT06150664·Phase 1·Recruiting·Listed Nov 2023

Apply to this trial